Evidence map›Paper›PMID 38271204›Full record

ArticleCell reports2024

Massively parallel disruption of enhancers active in human neural stem cells.

Evan Geller, Mark A Noble, Matheo Morales, Jake Gockley, Deena Emera, Severin Uebbing, Justin L Cotney, James P Noonan

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. CRISPR-based functional genomics tools in vertebrate models.Experimental & molecular medicine · 2025
    Review
  11. Article
  12. Reconstructing human-specific regulatory functions in model systems.Current opinion in genetics & development · 2024
    Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Regulatory landscape in brain development and disease.Current opinion in genetics & development · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Evan GellerDepartment of Genetics, Yale School of Medicine, New Haven, CT 06510, USA.
Mark A NobleDepartment of Genetics, Yale School of Medicine, New Haven, CT 06510, USA.
Matheo MoralesDepartment of Genetics, Yale School of Medicine, New Haven, CT 06510, USA.
Jake GockleyDepartment of Genetics, Yale School of Medicine, New Haven, CT 06510, USA.
Deena EmeraDepartment of Genetics, Yale School of Medicine, New Haven, CT 06510, USA.
Severin UebbingDepartment of Genetics, Yale School of Medicine, New Haven, CT 06510, USA.
Justin L CotneyDepartment of Genetics, Yale School of Medicine, New Haven, CT 06510, USA.
James P NoonanDepartment of Genetics, Yale School of Medicine, New Haven, CT 06510, USA; Department of Neuroscience, Yale School of Medicine, New Haven, CT 06510, USA; Wu Tsai Institute, Yale University, New Haven, CT 06510, USA. Electronic address: james.noonan@yale.edu.
Yale University · US

Funding

GENETICS AND GENOMICS OF HUMAN DISEASET32HD007149 · NICHD · YALE UNIVERSITY · PI James P Noonan · 1985 to 2026
$8.2M
Identifying enhancers with human-specific developmental functionsR01GM094780 · NIGMS · YALE UNIVERSITY · PI NOONAN, JAMES P · 2010 to 2018
$5.8M
Unraveling mechanisms of genome regulation to understand and improvehuman healthR35GM119465 · NIGMS · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI COTNEY, JUSTIN LEE · 2016 to 2025
$3.9M
Modeling uniquely human developmental gene regulatory networks using humanized miceR01HD102030 · NICHD · YALE UNIVERSITY · PI NOONAN, JAMES P · 2020 to 2024
$2.8M
NICHD NIH HHS R01 HD102030NICHD NIH HHS T32 HD007149NIGMS NIH HHS R01 GM094780NIGMS NIH HHS R35 GM119465
6 · The paper itself

Abstract

Changes in gene regulation have been linked to the expansion of the human cerebral cortex and to neurodevelopmental disorders, potentially by altering neural progenitor proliferation. However, the effects of genetic variation within regulatory elements on neural progenitors remain obscure. We use sgRNA-Cas9 screens in human neural stem cells (hNSCs) to disrupt 10,674 genes and 26,385 conserved regions in 2,227 enhancers active in the developing human cortex and determine effects on proliferation. Genes with proliferation phenotypes are associated with neurodevelopmental disorders and show biased expression in specific fetal human brain neural progenitor populations. Although enhancer disruptions overall have weaker effects than gene disruptions, we identify enhancer disruptions that severely alter hNSC self-renewal. Disruptions in human accelerated regions, implicated in human brain evolution, also alter proliferation. Integrating proliferation phenotypes with chromatin interactions reveals regulatory relationships between enhancers and their target genes contributing to neurogenesis and potentially to human cortical evolution.

Indexed as

Neural Stem CellsRNA, Guide, CRISPR-Cas SystemsCerebral CortexChromatinEnhancer Elements, GeneticHumansChromatinRNA, Guide, CRISPR-Cas SystemsCP: GenomicsCP: Neuroscienceenhancersgene regulationhuman accelerated regionshuman neural stem cellsneurodevelopmentneurodevelopmental disorders

Identifiers

PMID38271204
PMCPMC11078116
OpenAlexW4391155184

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.